ICICI Prudential Asset Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

ICICI Prudential Asset Management’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-20,095	Closed	-$5.63M	–	158
2025 Q3	$5.63M	Sell	20,095 -8,221	-29%	-$2.24M	0.59%	53
2025 Q2	$6.83M	Hold	28,316	–	–	0.85%	35
2025 Q1	$6.9M	Hold	28,316	–	–	0.9%	35
2024 Q4	$9.3M	Hold	28,316	–	–	1.02%	25
2024 Q3	$9.47M	Buy	28,316 +14,700	+108%	+$4.67M	1%	28
2024 Q2	$3.72M	Buy	+13,616	New	+$3.96M	0.44%	67

Other funds holding BIO

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VAM

Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

ICICI Prudential Asset Management's BIO Position: Q4 2025 in Review

ICICI Prudential Asset Management sold out of Bio-Rad Laboratories Class A (BIO) in Q4 2025, closing a stake of 20,095 shares — an estimated $5.63M sold.

ICICI Prudential Asset Management first reported a position in BIO in Q2 2024 and held it in 6 quarters. The position peaked at $9.47M in Q3 2024. 398 funds tracked by Wall St. Rank hold BIO as of Q4 2025.

ICICI Prudential Asset Management reported no remaining Bio-Rad Laboratories Class A position as of Q4 2025 after selling out during the quarter.
ICICI Prudential Asset Management sold 20,095 Bio-Rad Laboratories Class A shares in Q4 2025, an estimated $5.63M.
ICICI Prudential Asset Management first reported a position in Bio-Rad Laboratories Class A in Q2 2024 and held it in 6 quarters.
ICICI Prudential Asset Management's Bio-Rad Laboratories Class A position peaked at $9.47M in Q3 2024.
398 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2025.

Based on ICICI Prudential Asset Management's 13F filing for Q4 2025, filed 12 Feb 2026.